Dated alert on Prometheus Biosciences filing for stock offering withdrawn
Dec 9 (Reuters) - An alert on Prometheus Biosciences Inc
RXDX.O filing for an offering of up to $250 million of common
stock has been withdrawn as the news is dated.
For the alerts on Prometheus' $250 million stock offering
from Dec. 7, click urn:newsml:reuters.com:*:nTUA8PDTZ1.
STORY_NUMBER: FWN32Z1Q5
STORY_DATE: 09/12/2022
STORY_TIME: 09:30:25
((bangalore.newsroom@thomsonreuters.com))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results